Exxon Mobil was upgraded by Bank of America Merrill Lynch and the raised price target caused stocks to get a lift in the morning session. However, the boost did not last long and stocks began to give back those gains. Ben Willis of Albert Fried notes many stocks being sold are ones with high margin requirements. Willis mostly sees a sector rotation happening out of the names and going into lower beta names. He also points out the biotech weakness at NASDAQ.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

More from Video

Lee Munson on the Market, Trade and the Possibility of a Recession

Lee Munson on the Market, Trade and the Possibility of a Recession

What's My Data Doing in the Cloud? -- 60 Seconds

What's My Data Doing in the Cloud? -- 60 Seconds

Here's Why Alphabet, Facebook and Amazon Earnings May Overshadow Tariff Worries

Here's Why Alphabet, Facebook and Amazon Earnings May Overshadow Tariff Worries

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players

Tilray CEO: Surging Cannabis Industry Is a Threat to Food and Drug Players